S1 Data - by Richard Junior Zapata Dongo (17912565)

Subjects:

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Subjects:

Verification of PLUS CYCLE^® signals during presumed sleep periods. by Akihiro Ohnishi (10989900)

Subjects:

Expression and correlation analysis of 20 DESRGs. by Wei He (131453)

Subjects:

Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models. by Richard Junior Zapata Dongo (17912565)

Subjects:

A summary of calibration standards (n = 3). by Ewa Paszkowska (21246702)

Subjects:

The characteristics of patient groups were used to prove the method’s applicability. by Ewa Paszkowska (21246702)

Subjects:

HRV Values. by Burhan Demirkıran (21601740)

Subjects:

miR-1247-3p was downregulated in CRC resistant cells. by Dequan Wang (6007007)

Subjects:

The observed MRM reactions. by Ewa Paszkowska (21246702)

Subjects:

ROS, K⁺ efflux and cathepsin B are required for NLRP3 activation. by Madhusoodhanan Suresh Kumar Meena Kumari (20896666)

Subjects:

Diagnostic value of the 8 hub genes in the GSE52093 dataset. by Wei He (131453)

Subjects:

Spatial and temporal variation of the mean abundance of juvenile corals at the 10 stations located on the three major habitats, for the five categories (all taxa pooled, Acroporida... by Radonirina Lebely Botosoamananto (13989736)

Subjects:

Comprehensive list of all SRGs. by Wei He (131453)

Subjects:

Differences in health-related quality of life indexes after disease onset between groups. by Ji Woong Chang (1829314)

Subjects:

Changes in subcutaneous fat thickness and muscle mass (Approximately here). by Burhan Demirkıran (21601740)

Subjects:

Overall comparison of <i>Anaplasma</i> spp. and <i>A. ovis</i> prevalence among the goats enrolled from three districts in Punjab during the present study. % prevalence is given in... by Sumaira Sumaira (21453523)

Subjects:

Data from qPCR analysis of eDNA and matching hemolymph timepoints. by Rachael M. Giersch (22331947)

Subjects:

Ba/F3 EML4-ALK^mutants exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

Subjects:

Intra- and inter-day precision and accuracy. by Ewa Paszkowska (21246702)

Subjects: